123 related articles for article (PubMed ID: 9482299)
1. Should use of intracoronary stents during percutaneous revascularisation be restricted?
Palmer N; Fort S; Starkey I; Shaw T; Northridge D
Lancet; 1998 Feb; 351(9100):416-7. PubMed ID: 9482299
[No Abstract] [Full Text] [Related]
2. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluation of the cost-effectiveness of coronary stenting: a societal perspective.
Cohen DJ
Am Heart J; 1999 May; 137(5):S133-7. PubMed ID: 10220616
[No Abstract] [Full Text] [Related]
3. [Cost analysis of percutaneous coronary intervention and coronary artery bypass grafting in Japan and USA].
Chino M; Sasaki T
Nihon Rinsho; 2003 Apr; 61 Suppl 4():632-7. PubMed ID: 12735043
[No Abstract] [Full Text] [Related]
4. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Coronary stents: a health system perspective.
Ahmad M
Am Heart J; 1999 May; 137(5):S142-4. PubMed ID: 10220618
[No Abstract] [Full Text] [Related]
5. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Coronary stents: an industry perspective.
Marshall PR
Am Heart J; 1999 May; 137(5):S138-41. PubMed ID: 10220617
[No Abstract] [Full Text] [Related]
6. Funding of coronary angioplasty and coronary stenting in public hospitals.
Harper RW
Aust N Z J Med; 1996 Feb; 26(1):3-4. PubMed ID: 8775519
[No Abstract] [Full Text] [Related]
7. Cost effectiveness of coronary revascularisation.
Birim O; Bogers AJ; Kappetein AP
EuroIntervention; 2010 Feb; 5(7):763-7. PubMed ID: 20142188
[No Abstract] [Full Text] [Related]
8. In-hospital costs associated with new percutaneous coronary devices.
Dick RJ; Popma JJ; Muller DW; Burek KA; Topol EJ
Am J Cardiol; 1991 Oct; 68(9):879-85. PubMed ID: 1927947
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of sirolimus-eluting stents.
Shrive FM; Manns BJ; Galbraith PD; Knudtson ML; Ghali WA;
CMAJ; 2005 Feb; 172(3):345-51. PubMed ID: 15684117
[TBL] [Abstract][Full Text] [Related]
10. PCI and stable coronary heart disease--COURAGE to change our minds?
Kakafika AI; Mikhailidis DP; Wierzbicki AS; Karagiannis A; Athyros VG
Curr Vasc Pharmacol; 2007 Jul; 5(3):173-4. PubMed ID: 17627560
[No Abstract] [Full Text] [Related]
11. PCI or CABG: which patients and at what cost?
Gershlick T; Thomas M
Heart; 2007 Oct; 93(10):1188-90. PubMed ID: 17890695
[No Abstract] [Full Text] [Related]
12. Drug-eluting coronary stents: faith and hope, but no charity.
Knudtson ML
CMAJ; 2007 Jan; 176(2):195-6. PubMed ID: 17179218
[No Abstract] [Full Text] [Related]
13. Economics and outcomes of coronary stenting: are stents right for everybody?
Weintraub WS
J Invasive Cardiol; 2000 Apr; 12(4):200-2. PubMed ID: 10785673
[No Abstract] [Full Text] [Related]
14. Effects of changing clinical practice on costs and outcomes of percutaneous coronary intervention between 1998 and 2002.
Denvir MA; Lee AJ; Rysdale J; Prescott RJ; Eteiba H; Starkey IR; Pell JP; Walker A
Heart; 2007 Feb; 93(2):195-9. PubMed ID: 16849373
[TBL] [Abstract][Full Text] [Related]
15. The economics of adjunctive therapies in coronary angioplasty: drugs, devices, or both?
Oh PI; Cohen EA; Mittmann N; Seung SJ
Can J Clin Pharmacol; 2004; 11(2):e202-11. PubMed ID: 15520474
[TBL] [Abstract][Full Text] [Related]
16. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).
Kaiser C; Brunner-La Rocca HP; Buser PT; Bonetti PO; Osswald S; Linka A; Bernheim A; Zutter A; Zellweger M; Grize L; Pfisterer ME;
Lancet; 2005 Sep 10-16; 366(9489):921-9. PubMed ID: 16154019
[TBL] [Abstract][Full Text] [Related]
17. Cost and therapeutic modification of intracoronary ultrasound-assisted coronary angioplasty.
Talley JD; Mauldin PD; Becker ER; Stikovac M; Leesar MA
Am J Cardiol; 1996 Jun; 77(15):1278-82. PubMed ID: 8677866
[TBL] [Abstract][Full Text] [Related]
18. Medical economic considerations of coronary stenting.
Szucs TD
Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
[TBL] [Abstract][Full Text] [Related]
19. Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease.
Farzaneh-Far A; Borges-Neto S
Circ Cardiovasc Imaging; 2011 Nov; 4(6):746-53. PubMed ID: 22086945
[No Abstract] [Full Text] [Related]
20. The euros and sense of stents: do we get value for money?
Annemans L
J Cardiovasc Med (Hagerstown); 2011 Dec; 12(12):878-82. PubMed ID: 22025203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
